New Multiple Sclerosis Treatment Option, Extavia
Links shared publicly online about this topic
Novartis launches Extavia, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis
novartis.com — “Basel, January 22, 2009 - Novartis has today announced the launch of Extavia, a new version of the standard-of-care for relapsing forms of multiple sclerosis (MS), providing patients and physicians with an alternative option to help manage this devastating disease.” View full resource at novartis.com
Most Recently Shared on January 22, 2009 at 12:25 pm By:
eyeonfda Pharma and Health Lawyer
Novartis launches Extavia®, a new therapeutic option for patients with multiple sclerosis - http://is.gd/gOML
Multiple Sclerosis: Advances in Research and Treatment
webmd.com — “While the cause of multiple sclerosis or MS is still not known, recent advances in treatments and new understanding about the disease offer great hope for the near future, researchers say.” View full resource at webmd.com
Most Recently Shared on May 13, 2010 at 9:59 pm By:
webMD: Multiple Sclerosis: Advances in Research and Treatment http://bit.ly/bxf8fr Full http://bit.ly/d0kLlZ
US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease
novartis.com — “Basel, August 17, 2009 - The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.” View full resource at novartis.com
Most Recently Shared on August 20, 2009 at 1:30 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves Novartis' Extavia® for treatment of MS - http://bit.ly/sM6J3
Multiple Sclerosis Treatment : Treatment Search Results on Healthline.com
healthline.com — “Find Multiple Sclerosis treatment options on Healthline Treatment Search, including 15 Tests, 5 Medical Procedures, 9 Prescribed Medications, 1 Self Care, 5 Herbs and Supplements, 2 Alternative Procedures. Treatment Search includes comprehensive information on standard, alternative and complimentary therapies.” View full resource at healthline.com
Most Recently Shared on December 8, 2010 at 11:24 am By:
Try this free Treatment Search tool to find tests & treatments for Multiple Sclerosis! http://sns.ly/hlg78
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia
medicalnewstoday.com — “Merck KGaA announced that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treatment of relapsing-remitting multiple sclerosis (MS)(1). Cladribine Tabl” View full resource at medicalnewstoday.com
Most Recently Shared on September 5, 2010 at 11:56 am By:
Merck's Cladribine Tablets For Multiple Sclerosis Approved In Australia: Merck KGaA announced that the Australian ... http://mnt.to/f/3JkB
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing Remitting MS
medicalnewstoday.com — “An advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form” View full resource at medicalnewstoday.com
Most Recently Shared on August 7, 2010 at 2:05 pm By:
MNT Pharma News Health News and Pharma
FDA Advisory Committee Unanimously Recommends Approval Of Novartis Investigational Treatment FTY720 To Treat Relapsing... http://mnt.to/3H7B
MS Society Calls On Stem Cell Researchers For Grant Applications
medicalnewstoday.com — “The MS Society has called for researchers and scientists to come forward with research projects investigating the potential benefit of stem cells in multiple sclerosis (MS). A new partner” View full resource at medicalnewstoday.com
Most Recently Shared on January 31, 2010 at 1:04 pm By:
MNT Stem Cell News Health News
MS Society Calls On Stem Cell Researchers For Grant Applications http://mnt.to/3wZ6 #stemcell
University Of Chicago First To Offer Newly Approved Drug For Multiple Sclerosis
medicalnewstoday.com — “The first oral medication for multiple sclerosis was approved by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multip” View full resource at medicalnewstoday.com
Most Recently Shared on September 23, 2010 at 1:05 pm By:
University Of Chicago First To Offer Newly Approved Drug For Multiple Sclerosis http://mnt.to/3Kc3 #multiplesclerosis
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 16, 2010 at 1:28 am By:
Multiple Sclerosis Drug Gilenya Approved in Russia: The Multiple Sclerosis drug, Gilenya, manufactured by Novartis... http://bit.ly/buTAb7
Multiple Sclerosis Drug Gilenya Approved in Russia | ThirdAge
thirdage.com — “The Multiple Sclerosis drug, Gilenya, manufactured by Novartis has been approved for use in Russia. The drug is a daily oral therapy for treating relapses of multiple sclerosis. Russia is the first country to approve the use of the drug for treating MS.” View full resource at thirdage.com
Most Recently Shared on September 15, 2010 at 11:26 pm By:
Multiple Sclerosis Drug Gilenya Approved in Russia http://bit.ly/b5Wg6T
Benefits and underutilization of ITB therapy for multiple sclerosis
news-medical.net — “A new scientific article has been published demonstrating the profound impact of spasticity on patients with multiple sclerosis and the benefits and underutilization of intrathecal baclofen (ITB) therapy from Medtronic, Inc. as a treatment option for these patients.” View full resource at news-medical.net
Most Recently Shared on February 4, 2011 at 3:28 pm By:
Stroke News: Benefits and underutilization of ITB therapy for multiple sclerosis: A new scientific article has... http://twurl.nl/e7lvwf
FDA approves fingolimod drug for multiple sclerosis
news-medical.net — “The first oral medication for multiple sclerosis was approved today by the Food & Drug Administration. Physicians praised the decision to approve the drug, called fingolimod, saying it would give multiple sclerosis patients new options for treatment.” View full resource at news-medical.net
Most Recently Shared on September 23, 2010 at 2:09 pm By:
FDA approves fingolimod drug for multiple sclerosis: The first oral medication for multiple sclerosis was approved... http://bit.ly/csWCyo
Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Therapy And First In A New Class
medicalnewstoday.com — “The Russian health authority, the Federal Service on Surveillance in Healthcare and Social Development, has granted approval for Gilenya® (fingolimod) 0.5 mg once-daily oral therapy for the tr” View full resource at medicalnewstoday.com
Most Recently Shared on September 12, 2010 at 1:00 pm By:
Novartis Announces Russian Regulatory Approval For Gilenya®, A Once-daily Oral Multiple Sclerosis Therapy And Firs... http://mnt.to/3JCZ
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 3, 2010 at 12:11 pm By:
Drugs and Devices OW OW Health
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck... http://bit.ly/aAu3a7 #drug
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia - Drugs.com MedNews
drugs.com — “Darmstadt, September 3, 2010 Merck KGaA announced today that the Australian Therapeutic Goods Administration (TGA) has approved Cladribine Tablets for the treat” View full resource at drugs.com
Most Recently Shared on September 4, 2010 at 11:41 am By:
Merck?s Cladribine Tablets for Multiple Sclerosis Approved in Australia: Darmstadt, September 3, 2010 – Merck KGaA... http://bit.ly/bhIY9L
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
